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PENICILLIN-MEDICINE FROM MOLD
By BANNS WIl~TZ
Duriny the 1~8t Jew lIlQlltM. 1Jorio"4 aen.ratiunal report have appeared ill
the prea8 about a lIelt' df'''(1 called penicilli" u·h·ich i8 81.ppoaed tu P086C88 ",imet/lolU'
lualilly prupcrties. ··Time... in 1:t" iaBUtI oj -'1.larch 15. 1941, 11'1:"t 80 Jur (JR to RUY:
"I'en,cilh" w,illIlUI.·c more lit.'cl< than war cal. 8pend," atld cven Clmrchillllwntioned
the 'lew drn(J in one oj Ilia speechu.
We hove jUlie rueiv(U! detailed moterial 0" pwicillin Jrom E;urope. (md Dr.
llUfI7l1i Wirtz oJ. 'hmlgllUi. who obta,;ned his degree ;n plwrmace'l/.;clJ at the Unit· rllity
oj liO'lll, Genna"y. telllJ our readers about the nalur and significance oj elle '/IC.,O
medicament in tlw jollowi'l(J areicle.-K.M.
RED BLOOD FROM GREEN LEAVES 205
or ftl1lgi, he laid the foundation for effective
coulltermCll.'lures. Once an enemy is rec-
ognized, it is possible to Jay bare his w('ak
points and to construct the necc8sary defen-
sive weapons. The same applies to the
infectious diseases. Starting Ollt from Koch's
applied to the deep wound by means of a
tube. In other cases a compress with
chlorophyll or an ointment containing chlo-
rophyll was applied. Serious bone diseases,
inflammation of the brain, and many oases
of mouth infections, angina vincenti, and
pyorrhEa alt'Wlam have been cured.
For quite a number of years, chlorophyll
preparations for injection have been markcted
by reputable firms for the treatment of
tuberculosis and arteriosclerosis. The Ameri-
can specialists Robert Ridpaths and T.
Carroll Davis have had excellent results in
the treatment of 1,000 cases of infections of
the respiratory organs. They reported that
they had not seen a single case treak>d with
chlorophyll where the patient had not been
either oompletely cured or at least shown
considerable improvement. Chlorophyll
tampons inserted in the nose during colds
have been outstandingly succossful in giving
instant relief. Patients with a cold in the
head or the nose were greatly relieved within
twenty-four hours.
How does chlorophyll destroy bacteria or
hamper their growth? Beyond the fact.s
that it strengthens the cell walls, hampers
the growth of the bacteria, and gives thc
body a chance to mobilize its own defenses.
doctors know very little. Perhaps there is
something in the theory that the effect
produced by chlorophyll is produced by its
hampering influence on the vitamin metabo-
lism of the bacteria, which latter are-like
humans and animals--dependent on the
presenco of cert.ain substances or a vitamin
character.
__ to employ chlorophyll to fight bacteria!
.. the best antiseptics usually have one
iildvUltage in that, if they are strong
IDOOgh to kiU the cau8CS of the disease, they
Gften disturb the function of the surround·
.. tissue at the same time. Might chloro-
.yU enable the body to fight the invading
l.Cteria and yet spare the tissue?
Laboratory experiments have shown that,
it itself, chlorophyll does not have the
power to kill off bacteria. But when it is in
llODtact with live tissue it seems to strength.
eo the ceLIs' power of resistance and to
hamper the growth of bacteria. Its specifio
Ibility of breaking down carbon dioxide and
releasing the oxygen spells doom for the
blcteria, which can only live in suppurating
JJOunds beyond the rcach of air. Even in
aenerous doses chlorophyll has shown no
irritating effect. The department for ex·
perimental pathology at Templo is now
preparing various ointments containing
ohlorophyll for all kinds of infeotions and is
experimenting with them. Incidentally,
aintments containing chlorophyll, usually in
~dition to sulfonamides, have already been
marketed in China.
Last year, a dozen well-known doctors
published their experiences with chlorophyll
in the American Journal of Surgery. All in
all, some 1,200 cases, from deep-seated
infections to superficial skin injuries, had
been treated by these men, and in case after
cue the report ended: case cured. Patients
arrived with a ruptured appendix and in·
cipient peritonitis; after the necessary opera-
tion, a chlorophyll solution was successfully
WHEN Robert Koch proved morethun sixty years ago that a certaingroup of diseases, now known under
the collective name of ··infectious diseases,"
bas its cause in the activity of numerous kinds
of tiny parasites such as~bacteria, protozoa,
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discovery, several methods for their preven-
tion or cure were developed. At first the
greatest success was achieved by the injec-
tion of the blood serum from animals that
have been inoculated with the respective
bacteria or their toxins. Such serums, when
introduced into the human body, provide it
with the necessary power to resist and
combat an infection by virtue of the anti·
bodies it contains. In addition to this
serum therapy, chemotherapy was evolved,
i.e., the treatment of the disease by chemical
reagents that have a toxic effect upon the
microorganism causing the disease, without
lleriously harming the patient.
The success of this latter method, the
wide employment of which began with
Germany's Gerhard Domagk's publication
on his experiments with sulfa drugs in 1935,
WIlS llO overwhelming that it appeared at
first as if this was the only promising method
of combating such infectious diseases as
pneumonia, typhoid, angina, scarlet fever,
or gonorrhea. Hence the experts of the
whole world turned their attention to testing
and impro"ing the sulfa drugs, with the
result that another promising discovery in
this field lay fallow for many years.
In 1928 Dr. Alexander Fleming, Professor
of Bacteriology at St. Mary's Hospital
Medical School, University of London, was
studying the growth and propert.ies of staphy.
lococci, a genus of cocci bacteria most com-
monly found in boils, abscesses, carbuncles
and similar suppurative processes. One day
he observed that part of the medium in
which he was culturing these staphylococci
had been invaded by mold. A few days
later, Dr. Fleming noticed that the mold
had cleared a wide, bacteriafree area between
itself and the staphylococci-perhaps had
killed them. Realizing the importance of
this phenomenon, he began to devote bis
attention to it. :First he identified that
part,icular mold as PeniciUium notatum, a
close relative to the ordinary mold, Penicil·
lium glaucum, that annoys us by its appear-
ance on stale bread, shoes, imperfectly
sealed preserves, etc. Dr. Fleming then
b'Tew the mold on a liquid medium in glass
containers. The mold lIecreted a substance
into t,he medium which was capable of
preventing the growth of disease-producing
microorganisms. Dr. Fleming named this
by-product penicillin.
Although several similar antibiotics-i.e.,
antibodies produced by bacteria to stem
the growth of their rivals-were known,
none had 80 far been employed su<:ee88fully
in medicine. The reasons for this were their
comparative toxicity and the difficulty of
producing them.
Fleming therefore examined his penicillin
especially for its toxic effect on the animal
organism and found that the medium con.
taining penicillin was no more poisonous to
animals than the pure medium. Above &11,
penicillin did not harm the white blood
corpuscles, the human organism's chief troope
of defense against harmful germs.
After the therapeutic effect of penicillin
had been proved by excellent results in the
treatment of infected wounds with a liquid
containing penicillin, the question of pro·
ducing it was studied. Although it bec&m8
possible in 1932 to raise the mold in a
synthetic medium, the penicillin itself could
not be extracted in a concentrated, stable
form without losing its effectiveness. Nu.
merous attempts to overcome this difficulty
were unsuccessful. And when in 1935 the
sulfa drugs, which c:>mbine normal condi.
tions of manufacture with their great effec·
tiveness and comparatively low toxicity,
commenced their triumphal march against
the infectious diseases, Dr. }~leming and
other researchers on penicillin believed that
the latter would hardly attain any practical
significance as an antiseptic beside the
sulfonamides.
With the increasing employment of the
sulfonamides, however, it became apparent
that, beside the various bacteria they succeed
in laying low, there are some germs which
are insufficiently or not at all affected. It
also turned out that the therapeutic result
depends to a large extent on whether the
drug can reach the focus of infection in an
effective concentration. In cases where the
infection has advanced to a stage at which
necrosis, phlegmon, or thrombosis has set in,
the chances of a cure have proved to be
limited.
Hence medical science began to seek for
means of closing these gaps. According to
the Shanghai TimeJJ Week of August 9, 1944,
Japanese research workers have been ex-
perimenting with penicillin for ten years.
In England Dr. H. W. Florey and Dr. E. B.
Chain of Oxford's Sir William Dunn School of
Pathology resumed the interrupted work with
penicillin. With the aid of a large research
team, they succeeded in developing a method
by which penicillin could be extracted from
the culture medium and rid-at least partial.
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the sensitiveness of this organic substance
which, in contraBt to the sulfa drugs, placed
great obstacles in the way of large-scale
manufacture. It took months of work on
the part of Dr. Florey's entire team to pro-
duce enough penicillin to treat one or two
patients. Moreover, the first man treated
showed violent by-effects in the form of fits
of shivering and rising temperature, which
were, however, traced to impurities which
it was later possible to remove. Researchers
successfully went to work to discover tech-
nical methods of production with a sufficient
yield, so that today it has become possible
to provide pure, concentrated penicillin
preparations on a comparatively large and
increasing scale. But it is doubtful whether
it will ever be possible to cover all require-
ments by the culture method, aa it is very
difficult to protect the mold from bacteria
in the air whose enzymes tend to destroy it.
This problem will hence only be fully solved
by the chemical synthesis of penicillin which,
although probably possible, has so far not
yet been effected. Before penicillin can be
synthesized, its exact chemical composition
must be known. However, the difficulties
involved in obtaining the absolutely pure
secretion of Penicalium 1wtatum (there a.re at
least 100,000 molds and fungi, and there are
always spores of some of these molds in the
air) have resulted in several formulas for
the chemical composition of penicillin having
been advanced so far. Some scientists
regard it as a peptide of the formula
~4H32N2012; others claim it to be a hydro-
aromatic compound C2,HStOlO..~2 or C14H I9
OaN or C2tHS6011N; and finally there i:; one
group of scientists who maintain that penicil-
lin is a nitrogenfree compound.
Nor is it possible to determine the weight
of the penicillin contained in a given solution
without an exact knowledge of the chemical
composition,although the exactdeterminat ion
of the penicillin content of such a solution
is essential to its therapeutical application.
Hence the biological test method has been
resorted to. That quantity of penicillin was
determined which, dissolved in 50 cc of meat
extract., was just able completely to arrest
the growth of a specific culture of Staphy-
loc()ccu8 aureus. This quantity was named
an Oxford unit, or also a Florey or HeatIey
unit. In view of the rapid secretion of
penicillin from the body, vast quantities of
these units are needed. In the case of
pneumococci infections, for inst.ance, the
amount of penicillin needed for a cure is
around 100,000 Oxford units, while there
impurities without destroying its
y. Now it became possible to study
_ bacteriological and pharmacological
~teristics of penicillin by means of
. ents on animals. The following im-
J,8$Dt facts were established :
(I) Absence of any toxic effects on mice
.'other animals.
f2) White blood corpuscles and tissue
tultures are not harmed by concentrations
Ievera1 hundred times greater than are
lIeCe88lU'y for preventing the growth of
IlIcteria.
(3) The efficacy is affected neither by
blood, pus, nor putrefaction of tissues.
(4) The efficacy is also scarcely affected
.y the number of bacteria present.
(5) Penicillin is absorbed when injected
iito muscle or blood stream.
(6) Penicillin is useless when given by
mouth aB it is destroyed by acid stomach
juices.
(7) Penicillin disappears from the blood
within two hours, being largely excreted in
~e urine; hence large doses must be given
at short intervals for several days.
. The examination of the efficacy of penicil-
lin on the germs of the various infectious
diseases showed that penicillin, too, is no
panacea against all pathogenic germs. The
following bacteria. proved to be particularly
lensitive to the drug: Streptococcus PYOf/enes
(suppurating wounds, puerperal fever);
Staphylococcu8 aureU8 (diseases of the bone,
,carbuncles); Streptococcus pneumQniae (pneu-
monia); Corynebacterium dl:phtheriae (diph-
theria); Clostridium welchi-i, septicum, oedema-
hens (gas gangrene) ; Neisseria gonorrhoeae
(gonorrhea); Neisseria meningitidis (meningi-
iis, typhus). Less sensitive were, on the
other hand, the germs causing typhoid fever.
',Wholly resistant were those of plague,
oholera, dysentery, and tuberculosis.
Penicillin's effectiveness consists in that it
prevents the dividing and multiplying of the
bacteria affected by it. The drug is, in
effect, as the technical term has it, a bac-
teriostatic, while most antiseptics as, for
example, carbolic acid, kill the bacteria
directly.
Although the characteristics of penicillin
were now known and the experiments on
animals had pro\ided good results, the
drug was still far from being introduced
into general medical practice. Again it was
have been reports on the curing of serioUI
streptococcus cases which mention the in-
jection of 830,000 to 7,900,000 Oxford units.
According to the latest information, there
are seven manufacturers in Great Britain
and 21 in America (two Canadian, the rest
US) now producing penicillin or soon to be
in production. America expecu about 200
billion units a month to be produced by the
end of the yeM. The American factories
will have a· top capacity of nine pounds
(almOllt i billion units) a day, compared
with a total production last year of about
15 pounds. Prices now vary from US$2.85
to $10 for 100,000 uniu (la,gt year's price:
$20).
The small quantities produced until re-
cently make it obvious that there are not
nearly as many reportll available on 8UCCe8ll-
ful treatment.s as was the case some ten
years ago when the sulfonamides were intro·
duced. Nevcrthele88, there exists already
enough material to permit the conclusion
that, in cases where sufficient quantities of
penicillin are obtainable, the drug can
produce amazing results.
By far the greatest experience has been
gained in the treating of war wounds with
penicillin. The bacteriologist Florey and
the surgeon Cairns of Oxford joined the
British troops in ~.orth Africa and Italy for
three months to make observatious on the
spot. After some initial failures. they ob-
tained very favorable results. The danger
of infection in the case of war wounds was
practically eliminated. The best results
were achieved by powdering the wounds
with a mixture of penicillin and sulfonamide.
Extremely impre88ivc results were at-
tained with penicillin in the treatment of
sulfonamide-resistant cases of gonorrhea
which, with few exceptioll1l, were cured in
two days. Numerous cases of otherwise
hopeless staphylococcus infections were also
cured with penicillin, among them osteomy-
letitis (inflammation of the bone marrow),
infections of the skin- and subcutaneous
tissues (furuncles, etc.), and other infectioll1l.
In the case of pnewnococcus and meningo.
coccus infections, experience has proved
favorable but not extensive, as here the
excellence of the sulfonamides is undisputed,
and there is no rea.son to employ penicillin
for diseases in which simpler methods lead
to· the same result. The same applies to a
large number of other infectious diseases,
such as arthritis, infections of the urinary
tract, infections of the noee, sinus, and ••
uloers, cellulitis, infections of the haudI,
burns, etc. Many authors report on es.
cellent results with penicillin in the t;reM.
ment of these diseases; but at the mOllltlll&
these fields of indication are of no practioil
significance. For almost the entire pl'ellllU
production goes to the armed forces for the
treatment of &1l kinds of wounds, only a
8Dl&1l surplus being released for the treat-
ment of civilians. Naturally, this limited
quantity is reserved mainly for such Cuel
where other drugs have failed.
Whether penicillin will hold its own beside
the proven medicaments used today, or
whether it may even repIaoe these, will only
become apparent when the medical world
can be supplied with unlimited quantities at
competitive prices, which is not yet the
case. It looks as if penicillin or similar
by-producu of other microorganisms, 8uch
as pyocyanase, tyrothricin, gramicidin,
claviformin, patulin, spinul08in, citrinin,
gliotoxin, aspergillin, flavicin, clavacin, and
actinomycin, may be able to close the gape
left by the sulfonamide therapy. Vmoos
reportll have already been published accord·
ing to which most human and animal patho-
genic germs can be arrested in their growth
by one or the other antibiotic. This is alao
true of the particularly insell1litive acid·
resisting bacilli. Indeed, even the tuber·
culosis bacillus, which is otherwise practically
impregnable, has been succe88fully attacked
by preventing its growth, not by penioillin,
but by actinomycin, an antibiotic a,nalogoul
to penicillin but obtained from a different
mold.
It would thus appear as if, wit.h the aid
of antibiotic and chemothera.peutic sub-
stances, practically all infectious diseases
will be preventable or curable in future. It
is also entirely within the realm of po88ibility
- and this is Florey's opinion too - that
an antibiotic will be obtained one day
from one of the countlo88 microorgan-
isms which will prove to be tho universal
cure for &1l diseases caWled by germs.
Perhaps a step in this direction has
already been made in Japan, where Pro·
fesser Dr. Masahiko Kuroya of the Tohoku
Imperial University and his assistant Dr.
Shikaji Kondo recently announced the
discovery of a new type of penicillin with
a fungus.growth-prevention power many
times greater than t,hat of Dr. Fleming's
penicillin.
